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age range of 41–90 years. COMP levels were analysed by monoclonal
antibody enzyme linked immunosorbent assay in duplicate. The fatty
acid proﬁle of collected serum provided information on over 57
fatty acids determined by Gas Chromatography, though this report
focuses on the n-3, n-6 and n-9 types. The tibial plateau excised
during surgery was imaged and both medial and lateral condyles were
graded individually according to the Outerbridge Classiﬁcation by two
experienced orthopaedic surgeons.
Results: COMP values, serum fatty acid proﬁles and Outerbridge
Classiﬁcations were compared, and signiﬁcant positive correlations exist
between Outerbridge Classiﬁcation and total n-9 fatty acids (r = 0.235,
p < 0.05), and Outerbridge Classiﬁcation and 18:2(n-6) (linoleic-acid) (r
= 0.287, p < 0.05). There was a signiﬁcant negative correlation between
Outerbridge Classiﬁcation and 20:4(n-6) (arachidonic acid) (r = −0.336,
p < 0.01). Signiﬁcant correlations were also found to exist between the
various fatty acid groups and also within the n-6 and n-3 groups, as
would be expected.
Conclusion: Signiﬁcant correlations between the degree of tibial condyle
degradation and the level of overall n-9, linoleic-acid and arachidonic
acid show these to be of potential use as biomarkers of disease
progression. The ﬁnding of both positive and negative correlations
between the Outerbridge Classiﬁcation and n-6 fatty acids might
be explained by the ability of mammals to convert linoleic acid to
arachidonic acid. It is acknowledged that early-stage OA and controls
are lacking from this data-set, and that Outerbridge Classiﬁcations are
obtained at end-point OA.
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Purpose: Alkaptonuria is a rare autosomal recessive condition resulting
from deﬁciency of homogentisate 1,2 dioxygenase (HGD) causing
inability to metabolise homogentisic acid (HGA). HGA levels in the
body become elevated and show high afﬁnity for collagenous tissues,
primarily articular cartilages of load bearing joints, where it polymerises
and deposits as a dark pigment; this process is ochronosis. Over time
ochronosis causes rapid and early onset joint arthropathy, mimicking
osteoarthritis (OA) in presentation. Little is known about how HGA and
pigment affect cartilage matrix. This study aims to examine the effects of
HGA and the pigment on matrix turnover of osteoarthritic AKU joints.
Methods: AKU (n=6), OA (n =12) and normal (NL from acute trauma,
n = 6) articular cartilages were obtained as surgical waste with IRB
approval. The soluble (GuHCl extracted) protein fractions were analysed
for glycosaminoglycan (GAG) content quantiﬁed by the dye-binding assay
with dimethylmethylene blue, total Cartilage Oligomeric Matrix Protein
(T-COMP) with monoclonal antibodies (mAbs) 16F12 and 17C10 (kindly
provided by Dr. V Vilim) and for the new deamidated-COMP (D-COMP)
with mAbs 61A12 and 17C10. GAG was normalized to total protein of
each sample and D-COMP was analyzed as a ratio to T-COMP. Statistical
analysis consisted of ANOVA with the Tukey-Kramer HSD post-hoc test
using JMP (SAS, Cary) software.
Results: Analysis of extractable GAG revealed a highly signiﬁcant
association with disease/cartilage type: AKU, OA, or NL (ANOVA
p < 0.0001). AKU cartilage shows a signiﬁcantly lower amount of
extractable GAG compared to both NL and OA (p < 0.0001). There was no
signiﬁcant difference between OA and NL although OA tended to be lower
than NL. GAG was also signiﬁcantly different by disease type for both
hips (p < 0.0001) and knees (p = 0.02). The ratio of D/T COMP was also
signiﬁcantly associated with disease/cartilage type (ANOVA p=0.017).
The ratio of D/T COMP in AKU vs NL and vs OA was signiﬁcantly
different (p = 0.028 and p=0.016 respectively), demonstrating that the
extractable COMP from AKU cartilages is quite aged. The D/T ratios were
not signiﬁcantly different between NL and OA. There were no associations
of GAG or D/T COMP with patient age.
Conclusions: These studies are the ﬁrst to analyze biomarkers of cartilage
matrix turnover in AKU tissues. Previous evidence shows cartilage matrix
in AKU does not turn over in a normal fashion, appearing impervious
to proteolytic enzymes. These results provide further insights into the
severely derangedmetabolism of AKU cartilages. Although AKUmanifests
as a rare OA phenotype, it is more extreme with much lower GAG
and much higher D/T COMP ratio indicative of severe degeneration and
absence of a repair response. Although we cannot be certain at this time
that GAG cannot be extracted due to being bound into the ochronotic
matrix, the signiﬁcantly higher D/T COMP ratio in the extractable protein
clearly indicates cartilage matrix in AKU is not turned over in a normal
manner, or even in a manner consistent with the pathological turnover
seen in OA. The clinical signiﬁcance of these results is important as
any potential therapeutic strategy would need to be given prior to
pigmentation occurring in the cartilage matrix of these individuals on
the basis of these results and would need to involve stimulation of a
cartilage reparative response.
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Purpose: Currently, treatment of osteoarthritis (OA) is either pain
relieving treatments or terminal surgery. Thus, the discovery and
development of new treatment strategies is needed. Proteases, such
as metalloproteinases and cathepsins, play a major role in the net
degradation of cartilage, and are therefore a natural target for drug
development. However, studies have suggested that inhibition of one
protease leads to a compensatory effects from another. We aim to
characterize the dynamics of the different proteases in normal and OA
cartilage. Furthermore, by testing the ability of a library of proteases to
degrade cartilage explants, and by inhibiting one type of proteases, we
aim to ﬁnd the proteases responsible for collagen type II and aggrecan
degradation and possible compensatory effects by other proteases.
Methods: We used an array of metallo- and cysteine-proteases (MMP-
1/3/7/9/13, ADAMTS-4/5, Cathepsin-K/B/D/L/S) to degrade the matrix
from human OA cartilage, independent of chondrocytes. Human OA
cartilage explants were metabolically inactivated by freeze-thaw cycles
and incubated individually for 9 h with the proteases ± MMP-inhibitor
(GM6001) or cysteine-inhibitor (E64), in an MMP- or cysteine-buffer
optimal for respective proteases.Furthermore, we cultured normal bovine
cartilage explants and murine femoral heads with the pro-inﬂammatory
cytokines, OSM + TNF-a ± inhibitors for 22 days. Biomarkers of cartilage-
degradation; AGNxII (aggrecan degradation), CTX-II (type II collagen
telopeptide fragment), CIIM (type II collagen C-terminal helical fragment)
and NBCII (type II collagen inter helical fragment) were used to evaluate
effects of the proteases and inhibitors on cartilage and femoral head
explants.
Results: MMP-3 and -7, and ADAMTS-4 and -5, all increased aggrecan
degradation (AGNxII), in human metabolic inactivated OA cartilage
incubated in buffer optimal for MMPs. GM6001 inhibited this release
of the aggrecan fragments. We did not see any release of AGNxII
fragments by MMP-1, -9 and -13. In addition, cathepsin-S increased
aggrecan degradation, whereas Cathepsin-K, -B, -D and -L decreased the
degradation of aggrecan. The cysteine inhibitor, E64, increased aggrecan
degradation in both MMP and cysteine buffer, and did not abrogate the
effects generated by the cathepsins on aggrecan. In the MMP buffer,
collagen type II degradation was only degraded with MMP-7 (CTX-II)
and MMP-9 (NBCII), which both could be inhibited by GM6001. In the
cysteine buffer, none of the cathepsins degraded collagen type II, whereas
GM6001 increased the degradation as assessed by all three markers (CTX-
II, CIIM and NBCII). Catabolic induced bovine cartilage increased aggrecan
(AGNxII) and collagen type II degradation (CIIM), which was inhibited by
GM6001 but increased in the presence of E64. Catabolic induced femoral
heads increased collagen type II degradation, which was inhibited by
GM6001, but we did not see any increase in presence of E64.
Conclusions: The presence and role of endogenous proteases probably
depend on the stage of OA, as we did not observe the same compensatory
effects in normal cytokine-stimulated cartilage as in OA cartilage when
incubated with E64. Thus more investigation on this topic may have
signiﬁcant value for development of new treatments for OA. Furthermore,
our data indicate that proteases are very dependent on extracellular
factors, as different buffers had signiﬁcant different inﬂuence on the
outcome.
